Joel Greenblatt fit · Magic Formula - ROIC élevé + EV/EBIT bas
Is BioCryst Pharmaceuticals, Inc. (BCRX) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
61/100
CSignaux mixtes
5/5 critères validés
Les critères de Joel Greenblatt, appliqués à BCRX
EBIT/EV yield ≥ 10%
clé14.8%
ROIC ≥ 25%
clé93.9%
EV/EBIT ≤ 12
6.8x
Gross margin ≥ 30%
97.7%
Comment BCRX se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$1.74B
PER (TTM)
-
ROIC (TTM)
-121.96%
Marge brute
18.89%
Autres analyses Joel Greenblatt
Questions fréquentes
What is BCRX's Joel Greenblatt fit score?
BCRX scores 61/100 on our Joel Greenblatt fit engine - grade C. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own BCRX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends BCRX.
How often is this score updated?
BCRX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Joel Greenblatt possède ou recommande BCRX personnellement.